🔗 Share this article

An underground economy for unlicensed slimming medications is propelled by TikTok fitness influencers and sellers on communication apps, according to recent findings.

Experimental Treatment Acquiring Popularity Via Social Media

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its supposed weight-reducing effects. Viewers are urged to message these profiles privately for source information, while also receiving promotional offers.

Thriving Commerce on Messaging Platforms

Additionally, a flourishing trade exists on Telegram, where communities with thousands of members share “before and after” photos, administration instructions and claims of next-day British shipping. Sellers market the substance there before redirecting customers to WhatsApp for purchases.

Understanding The Experimental Drug

This medication is an experimental injectable developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could help patients lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.

Healthcare Professionals Voice Concerns

Nevertheless, physicians and pharmacists have warned that the distribution of what remains an unlicensed medication in the UK is worrisome and could result in individuals injecting products of uncertain source.

Some experts stated the demand for retatrutide could be linked to the rising cost of licensed slimming products such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unapproved medication that cannot be promoted or distributed for human use under the British medical regulations.

Several influencers try to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still violate pharmaceutical, marketing, and customer regulations, potentially leading to penalties, prosecution or prison.

Platform Response and Content Elimination

Based on TikTok, the platform has taken down problematic material and banned related hashtags and query recommendations. The organization said it was committed to keeping the platform safe and investing in strengthening enforcement strategies.

Online Trading Activities

Research also discovered groups with up to 9,000 participants marketing the experimental drug using the platform's integrated search feature, which functions like a online catalog. Typing “retatrutide” instantly brings up groups with thousands of members, populated with images of weight loss, positive reviews and detailed guides for preparing or injecting at home.

Within moments of entering one group, a seller shared WhatsApp details, where most purchases take place. The seller provided an guidebook and promised shipping within two days. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another shared a image of a supposed testing documentation. None inquired about body mass, health issues or previous experience.

Product Information and Pricing

Within these communities, messages show dark colored parcels with postal service stickers, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at residence with purified liquid, or ready-to-use pens usually sold at £160 for 20 milligrams. When asked how long a injector should last, sellers give contradictory responses ranging from a several days to “depends on your body”.

Platform Moderation and Security Measures

A spokesperson for the messaging service stated it actively monitored harmful material on its platform including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are injecting materials they cannot confirm. Although the science behind retatrutide is sound, these online versions may not include what they advertise,” stated a pharmacy expert, the head of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the increase in demand to current cost increases for approved slimming drugs such as Mounjaro. “With costs increasing, patients are turning to online platforms. But fake injections are highly risky. You can’t be certain what’s inside or whether the conditions they were produced in was sterile,” she said.

Her staff has already seen patients injured by self-injection from unverified suppliers. “We understand the frustration, but purchasing from messaging apps or communication platforms is taking chances with your health,” stated the doctor. “These substances could be contaminated or improperly measured.”

Producer Statement

A representative from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a Lilly investigational substance not yet authorized … may expose users to potentially significant medical dangers”.